July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Effects of Ca2+-channel blockers on photoreceptor Ca2+-levels and activity of calpains
Author Affiliations & Notes
  • Soumyaparna Das
    Institute for Ophthalmic Research, University of tuebingen, Tuebingen, Germany
    Graduate School of Cellular and Molecular Neuroscience, Tuebingen, Germany
  • Michael Power
    Institute for Ophthalmic Research, University of tuebingen, Tuebingen, Germany
    Graduate School of Cellular and Molecular Neuroscience, Tuebingen, Germany
  • Luke Rogerson
    Werner Reichardt Centre for Integrative Neuroscience, Germany
  • Thomas Euler
    Werner Reichardt Centre for Integrative Neuroscience, Germany
  • Francois Paquet-Durand
    Institute for Ophthalmic Research, University of tuebingen, Tuebingen, Germany
  • Footnotes
    Commercial Relationships   Soumyaparna Das, None; Michael Power, None; Luke Rogerson, None; Thomas Euler, None; Francois Paquet-Durand, None
  • Footnotes
    Support  PA1751/8-1
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 436. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Soumyaparna Das, Michael Power, Luke Rogerson, Thomas Euler, Francois Paquet-Durand; Effects of Ca2+-channel blockers on photoreceptor Ca2+-levels and activity of calpains. Invest. Ophthalmol. Vis. Sci. 2019;60(9):436.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinitis pigmentosa (RP) is a rare hereditary retinopathy which leads to primary rod degeneration followed by secondary cone loss. RP mutations often lead to accumulation of cGMP and over-activation of Cyclic Nucleotide Gated Channels (CNGC) in the photoreceptor outer segments. CNGC in turn mediate Ca2+-influx. High Ca2+ concentrations are believed to cause rod photoreceptor degeneration by activating Ca2+-dependent calpain-type proteases. An additional source of Ca2+ in rods is the Voltage Gated Calcium Channels (VGCC). Genetic knockout of CNGC showed improved rod viability and cone function, whereas VGCC knockout showed no improvement. Here, we further explore the role of CNGC and VGCC in photoreceptor degeneration using specific pharmacological inhibitors.

Methods : We used L-cis-diltiazem and D-cis-diltiazem, two enantiomers that are known to selectively block CNGC and VGCC, respectively. Their efficacy, at a concentration of 100 µM, was tested on organotypic retinal explant cultures derived from rd1 and wild-type (wt) animals, and cultured under controlled, serum-free conditions. This was followed by histological processing and assays for calpain activity and cell death (TUNEL). Furthermore, the effects of the compounds on Ca2+ dynamics in cone photoreceptors were tested using two-photon imaging.

Results : Our initial results showed 330% higher numbers of calpain activity positive cells per 1000 µm2 in the rd1 ONL (1.18 ± 0.08, n=4), as compared to wt (0.36 ± 0.03, n=4). With L-cis-diltiazem treatment, calpain activity positive cells decreased by 30% in rd1 ONL (0.91 ± 0.07, n=3). The treatment with D-cis-diltiazem decreased calpain activity positive cells in rd1 by 34% (0.88 ± 0.07, n=2). Yet, D-cis-diltiazem increased the calpain positive cell count in wt ONL by 45% (0.66 ± 0.06, n=2). Ca2+-imaging showed a reduction in Ca2+ baseline for both D-cis-diltiazem and L-cis-diltiazem. However, D-cis-diltiazem did not affect the light induced Ca2+ response in cones, while L-cis-diltiazem strongly suppressed this response.

Conclusions : Our preliminary data suggests that pharmacological block of both VGCC and CNGC can decrease photoreceptor Ca2+ levels and the activity of calpains. The differential effect of L-cis- and D-cis diltiazem on light-induced responses indicates that only CNGC inhibition can reduce Ca2+-levels in photoreceptor outer segments.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×